DURECT (DRRX) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free DRRX Stock Alerts $1.71 +0.36 (+26.67%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | americanbankingnews.comDURECT (NASDAQ:DRRX) Earns Neutral Rating from HC WainwrightMay 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)May 22, 2024 | americanbankingnews.comDURECT (NASDAQ:DRRX) Rating Increased to Hold at StockNews.comMay 21, 2024 | msn.comDURECT gets FDA breakthrough therapy status for larsucosterolMay 21, 2024 | prnewswire.comDURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated HepatitisMay 14, 2024 | msn.comDURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comDurect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...May 13, 2024 | prnewswire.comDURECT Corporation Reports First Quarter 2024 Financial Results and Business UpdateMay 12, 2024 | msn.comDURECT Q1 2024 Earnings PreviewMay 7, 2024 | prnewswire.comDURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateApril 30, 2024 | prnewswire.comDURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisApril 1, 2024 | finance.yahoo.comDURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | benzinga.comDurect: Q4 Earnings InsightsMarch 27, 2024 | markets.businessinsider.comDURECT Corp. Q4 Loss decreases, beats estimatesMarch 27, 2024 | finance.yahoo.comDURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 27, 2024 | msn.comOptions Volatility and Implied Earnings Moves Today, March 27, 2024March 27, 2024 | msn.comDURECT Q4 2023 Earnings PreviewMarch 20, 2024 | finance.yahoo.comDURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateMarch 20, 2024 | prnewswire.comDURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateMarch 16, 2024 | finance.yahoo.comDRRX Apr 2024 5.000 callMarch 16, 2024 | finance.yahoo.comDRRX Apr 2024 0.500 putMarch 4, 2024 | markets.businessinsider.comDURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product LineMarch 4, 2024 | msn.comDURECT and Charles River enter agreement for alzet in U.S., CanadaMarch 4, 2024 | finance.yahoo.comDURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaFebruary 24, 2024 | finance.yahoo.comDRRX Mar 2024 1.500 putFebruary 7, 2024 | finance.yahoo.comDURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceJanuary 29, 2024 | msn.comEarth Science Tech to effect up to $5M stock repurchase programNovember 16, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Taysha Gene Therapies (TSHA) and Durect (DRRX)November 15, 2023 | seekingalpha.comDURECT: Reading Into AHFIRM Mortality RatesNovember 13, 2023 | benzinga.comRecap: Durect Q3 EarningsNovember 13, 2023 | finance.yahoo.comDURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNovember 12, 2023 | morningstar.comDurect Corp DRRXNovember 10, 2023 | benzinga.com4DRRX : Durect Earnings PreviewNovember 10, 2023 | msn.comJonesTrading Downgrades Durect (DRRX)November 9, 2023 | finance.yahoo.comDURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNovember 9, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Durect (DRRX) and Praxis Precision Medicines (PRAX)November 9, 2023 | msn.comWhy Is Pain & Liver Disease Focused DURECT Stock Plunging Today?November 8, 2023 | msn.comCrude Oil Falls 2.5%; Ralph Lauren Posts Upbeat EarningsNovember 8, 2023 | msn.comUS Stocks Higher; Kellanova Sales Top EstimatesNovember 8, 2023 | marketwatch.comDurect Shares Plummet Premarket After Larsucosterol Study MissNovember 8, 2023 | msn.comDurect plummets as lead asset fails in mid-stage trial for liver disorderNovember 7, 2023 | finance.yahoo.comDURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNovember 7, 2023 | marketbeat.comTrading was temporarily halted for "DRRX" at 04:11 PM with a stated reason of "News pending."September 14, 2023 | msn.comNorthland sees DURECT's upcoming data as "major" catalyst for stockSeptember 14, 2023 | seekingalpha.comNorthland sees DURECT's upcoming data as "major" catalyst for stock (update)September 7, 2023 | finance.yahoo.comDURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisAugust 31, 2023 | finance.yahoo.comDURECT Corporation Announces Presentations in Upcoming Investor ConferencesAugust 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Durect (DRRX) and Cytokinetics (CYTK)August 11, 2023 | msn.comCantor Fitzgerald Maintains Durect (DRRX) Overweight RecommendationAugust 11, 2023 | msn.comHC Wainwright & Co. Maintains Durect (DRRX) Buy Recommendation Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. DRRX Media Mentions By Week DRRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRRX News Sentiment▼1.260.79▲Average Medical News Sentiment DRRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRRX Articles This Week▼11▲DRRX Articles Average Week Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EYEN News Today FBIO News Today JAGX News Today VYNE News Today CARA News Today NRXP News Today UNCY News Today CASI News Today LEXX News Today HCWB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRRX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
